Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The effect of intravenous immunoglobulin on neuromyelitis optica.
The ophthalmological complications of targeted agents in cancer therapy: what do we need to know as ophthalmologists?
Reversible blindness in bilateral optic neruritis associated with nasal flu vaccine.
Screening for MOG-IgG and 27 other anti-glial and anti-neuronal autoantibodies in 'pattern II multiple sclerosis' and brain biopsy findings in a MOG-IgG-positive case.
Cerebrospinal fluid analysis.
Tumefactive demyelination: an approach to diagnosis and management.
The therapeutic value of yoga in neurological disorders.
Effectiveness of Energy-Conservation treatment in reducing fatigue in Multiple Sclerosis: a systematic review and meta-analysis.
The behavior-analytic origins of constraint-induced movement therapy: an example of behavioral neurorehabilitation.
Imatinib-induced amelioration of neurologic deficits in a rare case of simultaneous association of missed multiple sclerosis and chronic myeloblastic leukemia.
Proresolution lipid mediators in multiple sclerosis - differential, disease severity-dependent synthesis - a clinical pilot trial.
Hope for a rare disease: eculizumab in neuromyelitis optica.
Clonal Expansion of Mitochondrial DNA Deletions and the Progression of Multiple Sclerosis.
Expanding the Clinical Indications for Alpha-1-Antitrypsin Therapy.
Apolipoprotein E polymorphisms status in Iranian patients with multiple sclerosis.
Minocycline effects on the CSF proteome of Experimental Autoimmune Encephalomyelitis rats.
MHC Mismatch Results in Neural Progenitor Cell Rejection Following Spinal Cord Transplantation in a Model of Viral-Induced Demyelination.
Xavier Montalban: a pioneer in understanding multiple sclerosis.
"People power" or "pester power"? YouTube as a forum for the generation of evidence and patient advocacy.
Deliberate Fingolimod Overdose Presenting with Delayed Hypotension and Bradycardia Responsive to Atropine.
Insights into the Mechanisms of the Therapeutic Efficacy of Alemtuzumab in Multiple Sclerosis.
Effect of natalizumab on oxidative damage biomarkers in relapsing-remitting multiple sclerosis.
Alcohol as a Modifiable Lifestyle Factor Affecting Multiple Sclerosis Risk.
Placebo-controlled study in neuromyelitis optica-Ethical and design considerations.
Postpartum complicated by transverse myelitis.

Pages